CDK4/6 Inhibitors in the Second-line Treatment Setting

Dr. Elizabeth Reed and Dr. Cynthia Ma discuss the future clinical benefits of these emerging inhibitors in the second-line treatment setting for patients with hormone-receptor-positive breast cancer. ... Author: imedex Added: 03/27/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts